Can You Convert 7-OH Milligrams to MIT? Why There Is No Reliable 1:1 Chart
Short answer: no reliable chart converts a stated number of 7-OH milligrams into an equivalent amount of mitragynine, an MIT tablet count, or a weight of MIT extract powder. A 1:1 table would combine different compounds, product matrices, laboratory units, and human responses into a precision that the evidence does not support.
This matters when 7-OH availability changes. Someone moving away from a concentrated 7-OH product may search for an MIT replacement, but a label-based conversion can create false confidence around two psychoactive substances that act differently at mu-opioid receptors.
Why a 7-OH milligram is not an MIT milligram
Mitragynine and 7-hydroxymitragynine are related alkaloids, not alternate names for the same molecule. Laboratory research shows that 7-OH has greater mu-opioid-receptor potency. Mitragynine also has activity at mu-opioid and other receptor systems and is metabolized partly to 7-OH, but that biological relationship is not a fixed retail conversion.
Two product labels can also use “mg” for different purposes. One may state an ingredient or product-line amount, while another COA may report a measured result per finished unit. An extract-powder report may use percent or milligrams per gram. The unit has meaning only when the analyte, matrix, sample, and method stay attached.
Common conversion shortcuts and why they fail
| Shortcut | What it mixes together | Why the answer is unreliable |
|---|---|---|
| 7-OH label mg ÷ MIT tablet label mg | Two different alkaloids and possibly two marketing fields | Equal mass does not mean equal receptor potency, absorption, or subjective effect |
| MIT tablet label mg ÷ powder percentage | A count-based finished product and a weight-based concentrate | The calculation ignores matrices, formulation, sample scope, and handling |
| One person’s 7-OH use × an online ratio | Personal tolerance and an unverified rule of thumb | Prior use, co-use, metabolism, health, and product composition vary |
| ND 7-OH on a COA = no opioid-like risk | A method-limited sample result and a safety conclusion | Mitragynine remains psychoactive and can involve dependence or withdrawal |
| Lower price per unit = comparable product | Purchasing economics and pharmacological effect | Cost math cannot establish chemical or clinical equivalence |
Current KP tablet and powder numbers describe different records
The current 150mg MIT Mango tablet line links to a Cora Science report for pressed Mitragynine Tablet lot M/150/002. That report lists 146mg mitragynine, 0.148mg 7-OH, and 153mg total Mitragyna alkaloids per unit. The 150mg text is the product-line label; the report figures are results for the identified finished-tablet lot.
The current MIT 90% powder line links to PharmLabs San Diego sample DD00126B(15), sample ID SD260715-011 (142956). It reports 87.01% mitragynine (870.12mg/g) for the submitted concentrate sample. The 90% text is the catalog line name; 87.01% is the sample result.
Putting these records beside a 7-OH label can help identify the products. It cannot reveal a tablet count or powder weight that will reproduce the 7-OH experience. The MIT Product Documents & COA Center keeps the full document relationships visible.
Human response adds more uncertainty
People consume 7-OH or MIT products under very different conditions. Product formulation, route, other ingredients, food, metabolism, tolerance, frequency of use, and other substances can change onset and effects. A person who has developed dependence may also experience withdrawal that cannot be managed safely by label arithmetic.
MIT is not an inert or risk-free fallback. It is psychoactive, and repeated use can involve tolerance, dependence, withdrawal, nausea, or sedation. Alcohol, opioids, benzodiazepines, sleep medicines, and other sedating substances can add risk. A laboratory document identifies a sample; it does not predict an individual response.
What to compare instead of effect equivalence
- Exact identity: 7-OH, mitragynine, MGPI, MGM-15, and MGM-16 are separate names.
- Physical format: tablet, powder, gummy, liquid, or botanical leaf.
- Label field: ingredient statement, product-line name, count, net weight, or another selector.
- Document scope: finished product, source material, submitted sample, or a shared reference.
- Analytical units: percent, mg/g, mg per unit, ppm, LOD, and LOQ.
- Destination rules: federal scheduling, FDA status, and state or local restrictions require separate checks.
For a format-only comparison, use MIT Tablets vs MIT Extract Powder. For the current federal distinction, use Is 7-OH Banned Right Now?
What to do when the question is really about withdrawal
A request for a conversion chart is sometimes a request for help stopping or reducing concentrated 7-OH. That is a health question rather than a shopping calculation. Severe symptoms, breathing difficulty, inability to stay awake, confusion, seizure, or suspected overdose require emergency help. In the United States, call 911 for an emergency or contact Poison Control at 1-800-222-1222 for immediate poison guidance.
For non-emergency support with substance use, a qualified clinician can assess the individual situation. The SAMHSA National Helpline provides free, confidential treatment referral and information in the United States. Neither a retailer nor an online ratio can replace that assessment.
How to choose a current MIT format without a conversion
Choose by verifiable format priorities. The tablet lane is count-based, pressed, Mango flavored, and linked to an identified finished-tablet report. The powder lane is weight-based, loose, unflavored, and linked to an identified concentrate-sample report. Both require current destination checks and secure storage.
The Legal 7-OH Alternative comparison places those practical differences beside the August 26 federal status without promising equal effects.
Compare current MIT formats by label and document
Compare identity, not an equivalency
The current tablet record and current powder record show different formats, units, package selectors, and laboratory relationships. Those records support product identification; they do not create a 7-OH-to-MIT conversion.
Official sources
- FDA information on concentrated 7-OH products
- FDA and Kratom
- DEA temporary order for MGPI, MGM-15, and MGM-16
- Human opioid-receptor pharmacology of mitragynine and 7-OH
- Metabolism of mitragynine to 7-OH
Featured image credit: Laboratory microscope by Akram Huseyn / Unsplash.
Product and risk information only; no medical, serving, tapering, withdrawal, or equivalency advice.
